Metastatic Breast Cancer, Triple Negative Breast Cancer Withdrawn Phase 2 Trials for Tipiracil (DB09343)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

IndicationStatusPhase
DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04149444A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast CancerTreatment